ExploreWatchlistsPricing
  1. JP-listed companies
  2. CellSeed Inc.
  3. Financials
  4. Gross profit

CellSeed Inc. (7776)

Market cap
¥8.3B
P/E ratio
-7x
Cellseed develops cell sheet regenerative medicine technology to treat diseases that conventional therapies cannot cure, serving researchers and patients globally.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndGross profit (Million JPY)YoY (%)
Dec 31, 202543-61.18%
Dec 31, 2024110+2.76%
Dec 31, 2023107+75.61%
Dec 31, 202261-27.39%
Dec 31, 202184-39.18%
Dec 31, 2020138-36.21%
Dec 31, 2019217-78.22%
Dec 31, 2018994+1849.15%
Dec 31, 201751-36.87%
Dec 31, 201681-46.09%
Dec 31, 2015150+301.05%
Dec 31, 201437

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat